Clinical Roundup NCCN provides COVID-19 treatment advice; updates vaccine guidance for cancer patients March 12, 2021Vol.47 No.10
Clinical Roundup UNC Lineberger review demonstrates benefits and harms from LDCT screening March 12, 2021Vol.47 No.10
Clinical Roundup National cancer genetic screening program at Emory offers at-home testing March 12, 2021Vol.47 No.10
Clinical Roundup Multisystem failure regarding frailty necessitates multisystem intervention March 12, 2021Vol.47 No.10
Drugs & Targets FDA approves Fotivda for relapsed or refractory advanced renal cell carcinoma March 12, 2021Vol.47 No.10
Drugs & Targets FDA grants accelerated approval to Yescarta for relapsed or refractory follicular lymphoma March 12, 2021Vol.47 No.10
Drugs & Targets Health Canada approves Keytruda as first-line treatment for adults with MSI-H or dMMR colorectal cancer March 12, 2021Vol.47 No.10
Drugs & Targets Surface Oncology, Merck to collaborate on immuno-oncology study evaluating SRF388, targeting IL-27 + Keytruda (pembrolizumab) in solid tumors March 12, 2021Vol.47 No.10
Drugs & Targets Syapse expands strategic collaboration with Pfizer, focusing on RWE March 12, 2021Vol.47 No.10
